Pediatric Arthritis Study of Certolizumab Pegol

NCT01550003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Polyarticular-course Juvenile Idiopathic Arthritis (JIA)

Interventions

DRUG: Certolizumab Pegol (CZP)
DRUG: Certolizumab Pegol (CZP)

Sponsor

UCB BIOSCIENCES GmbH

Collaborators

[object Object]